1. Home
  2. EVO vs WINA Comparison

EVO vs WINA Comparison

Compare EVO & WINA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • WINA
  • Stock Information
  • Founded
  • EVO 1993
  • WINA 1988
  • Country
  • EVO Germany
  • WINA United States
  • Employees
  • EVO N/A
  • WINA N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • WINA Other Specialty Stores
  • Sector
  • EVO Health Care
  • WINA Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • WINA Nasdaq
  • Market Cap
  • EVO 1.4B
  • WINA 1.4B
  • IPO Year
  • EVO 2021
  • WINA 1993
  • Fundamental
  • Price
  • EVO $3.31
  • WINA $418.44
  • Analyst Decision
  • EVO Strong Buy
  • WINA
  • Analyst Count
  • EVO 1
  • WINA 0
  • Target Price
  • EVO $7.00
  • WINA N/A
  • AVG Volume (30 Days)
  • EVO 54.5K
  • WINA 73.5K
  • Earning Date
  • EVO 11-05-2025
  • WINA 10-15-2025
  • Dividend Yield
  • EVO N/A
  • WINA 2.71%
  • EPS Growth
  • EVO N/A
  • WINA 2.56
  • EPS
  • EVO N/A
  • WINA 11.21
  • Revenue
  • EVO $887,396,457.00
  • WINA $84,517,400.00
  • Revenue This Year
  • EVO N/A
  • WINA $7.05
  • Revenue Next Year
  • EVO $10.78
  • WINA $3.60
  • P/E Ratio
  • EVO N/A
  • WINA $37.29
  • Revenue Growth
  • EVO N/A
  • WINA 3.35
  • 52 Week Low
  • EVO $2.84
  • WINA $295.79
  • 52 Week High
  • EVO $5.64
  • WINA $527.37
  • Technical
  • Relative Strength Index (RSI)
  • EVO 28.61
  • WINA 43.12
  • Support Level
  • EVO $3.30
  • WINA $388.15
  • Resistance Level
  • EVO $4.09
  • WINA $430.30
  • Average True Range (ATR)
  • EVO 0.09
  • WINA 18.10
  • MACD
  • EVO -0.08
  • WINA 1.53
  • Stochastic Oscillator
  • EVO 2.06
  • WINA 51.90

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About WINA Winmark Corporation

Winmark Corp is a franchisor of value-oriented retail store concepts that buy, sell, and trade gently used merchandise. The company has one reportable segment including Franchising and one non-reportable segment Leasing. The franchising segment franchises value-oriented retail store that buys, sell, trade, and consign merchandise as well as provide strategic consulting services relating to franchising. The leasing segment includes middle-market equipment leasing business and small-ticket financing business. It generates a majority of its revenue from the Franchising segment.

Share on Social Networks: